According to AlGhatrif et al., age is a key factor regulating ACE2 expression and its implication in COVID-19, with older patients with CVD exhibiting lower ACE2 levels and higher RAS signaling, while younger patients without CVD show higher ACE2 levels and lower RAS signaling. The gene discussed is ACE2; the disease is COVID-19.